Importer of Controlled Substances Application: Cambridge Isotope Laboratories, 19083-19084 [2017-08346]
Download as PDF
<![CDATA[
19083
Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Dated: April 18, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–08232 Filed 4–24–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
December 16, 2016, Janssen Ortho LLC,
State Road 933 DM 0.1 Mamey Ward,
Gurabo, Puerto Rico 00778 applied to be
registered as an importer of tapentadol
(9780), a basic class of controlled
substance listed in schedule II.
The company plans to import an
intermediate form of tapentadol (9780)
to bulk manufacture tapentadol for
distribution to its customers.
[Docket No. DEA–392]
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
Importer of Controlled Substances
Application: Janssen Ortho LLC
[FR Doc. 2017–08345 Filed 4–24–17; 8:45 am]
ACTION:
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
May 25, 2017. Such persons may also
file a written request for a hearing on
the application pursuant to 21 CFR
1301.43 on or before May 25, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
DATES:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4410–09–P
Notice of application.
VerDate Sep<11>2014
17:42 Apr 24, 2017
Jkt 241001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cedarburg
Pharmaceuticals
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before June 26, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
DATES:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
In accordance with 21 CFR
1301.33(a), this is notice that on June 1,
2016, Cedarburg Pharmaceuticals Inc., A
Division of Albany Molecular Research
Inc. (AMRI), 870 Badger Circle, Grafton,
Wisconsin 53024 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled Substance
Marihuana ...................
Tetrahydrocannabinols
Lisdexamfetamine ......
4-Anilino-N-phenethyl4-piperidine (ANPP).
Remifentanil ................
Fentanyl ......................
Drug
Code
Schedule
7360
7370
1205
8333
I
I
II
II
9739
9801
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
In reference to drug codes 7360
marihuana, the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic
tetrahydrocannabinols 7370. No other
activity for this drug code is authorized
for this registration.
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–08343 Filed 4–24–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cambridge Isotope
Laboratories
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before May 25, 2017. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before May 25,
2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
DATES:
E:\FR\FM\25APN1.SGM
25APN1
19084
Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on August
25, 2016, Cambridge Isotope
Laboratories, 50 Frontage Road,
Andover, Massachusetts 01810 applied
to be registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ..................................................................................................................
Gamma Hydroxybutyric Acid .........................................................................................................................................
Methaqualone ................................................................................................................................................................
Lysergic acid diethylamide ............................................................................................................................................
Marihuana ......................................................................................................................................................................
Tetrahydrocannabinols ..................................................................................................................................................
3,4-Methylenedioxyamphetamine ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .....................................................................................................................
3,4-Methylenedioxymethamphetamine ..........................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ....................................................................................................
Butylone .........................................................................................................................................................................
Heroin ............................................................................................................................................................................
Pentobarbital ..................................................................................................................................................................
Secobarbital ...................................................................................................................................................................
Phencyclidine .................................................................................................................................................................
Cocaine ..........................................................................................................................................................................
Dihydrocodeine ..............................................................................................................................................................
Ecgonine ........................................................................................................................................................................
Meperidine .....................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................
Fentanyl .........................................................................................................................................................................
The company plans to import the
listed controlled substances for
analytical research, testing and clinical
trials.
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–08346 Filed 4–24–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
asabaliauskas on DSK3SPTVN1PROD with NOTICES
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before June 26, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
SUPPLEMENTARY INFORMATION:
Drug code
Gamma Hydroxybutyric Acid .........................................................................................................................................
Dihydromorphine ............................................................................................................................................................
Hydromorphinol ..............................................................................................................................................................
Methylphenidate .............................................................................................................................................................
Amobarbital ....................................................................................................................................................................
Pentobarbital ..................................................................................................................................................................
Secobarbital ...................................................................................................................................................................
17:42 Apr 24, 2017
Jkt 241001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 22, 2016, Siegfried USA,
LLC, 33 Industrial Park Road,
Pennsville, New Jersey 08070 applied to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Controlled substance
VerDate Sep<11>2014
1248
2010
2565
7315
7360
7370
7400
7404
7405
7540
7541
9200
2270
2315
7471
9041
9120
9180
9230
9273
9801
Schedule
E:\FR\FM\25APN1.SGM
25APN1
2010
9145
9301
1724
2125
2270
2315
Schedule
I
I
I
II
II
II
II
]]>Agencies
[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)]
[Notices]
[Pages 19083-19084]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08346]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Cambridge Isotope
Laboratories
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before May 25, 2017. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before May 25, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement
[[Page 19084]]
Administration, Attn: Administrator, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for hearing should also be
sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ,
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug
Enforcement Administration, Attn: DEA Federal Register Representative/
DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers importers, and exporters of,
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on August
25, 2016, Cambridge Isotope Laboratories, 50 Frontage Road, Andover,
Massachusetts 01810 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
Gamma Hydroxybutyric Acid........... 2010 I
Methaqualone........................ 2565 I
Lysergic acid diethylamide.......... 7315 I
Marihuana........................... 7360 I
Tetrahydrocannabinols............... 7370 I
3,4-Methylenedioxyamphetamine....... 7400 I
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine... 7405 I
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone............................ 7541 I
Heroin.............................. 9200 I
Pentobarbital....................... 2270 II
Secobarbital........................ 2315 II
Phencyclidine....................... 7471 II
Cocaine............................. 9041 II
Dihydrocodeine...................... 9120 II
Ecgonine............................ 9180 II
Meperidine.......................... 9230 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Fentanyl............................ 9801 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
analytical research, testing and clinical trials.
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-08346 Filed 4-24-17; 8:45 am]
BILLING CODE 4410-09-P
